Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Kazdal

Showing results (31-40 of 116) with videos related to

Pageof 12
Sort By:
Proteomics|December 14, 2017
Proteomics in PathologyRémi Longuespée, Rita Casadonte, Kristina Schwamborn, et al.
Proteomics. Clinical Applications|August 13, 2017
MALDI Imaging-Guided Microproteomic Analyses of Heterogeneous Breast Tumors-A Pilot StudyDeborah Alberts, Charles Pottier, Nicolas Smargiasso, et al.
NPJ Precision Oncology|July 3, 2026
Mutation enrichment in targeted panels flags immunotherapy-responsive POLE-driven hypermutated microsatellite-stable colorectal cancersNic Gabriel Reitsam, Kathrin Anna Schneider, Bianca Grosser, et al.
Case Reports in Oncology|May 12, 2021
Combination of Crizotinib and Osimertinib in T790M+ EGFR-Mutant Non-Small Cell Lung Cancer with Emerging MET Amplification Post-Osimertinib Progression in a 10-Year Survivor: A Case ReportMiriam Blasi, Daniel Kazdal, Michael Thomas, et al.
Proteomics. Clinical Applications|September 15, 2018
In MALDI-Mass Spectrometry Imaging on Formalin-Fixed Paraffin-Embedded Tissue Specimen Section Thickness Significantly Influences m/z Peak IntensityRémi Longuespée, Katharina Kriegsmann, Martin Cremer, et al.
Cell Death Discovery|April 14, 2023
Homogenous TP53mut-associated tumor biology across mutation and cancer types revealed by transcriptome analysisEva Romanovsky, Klaus Kluck, Iordanis Ourailidis, et al.
Pathology, Research and Practice|March 1, 2018
Analysis of the proliferative activity in lung adenocarcinomas with specific driver mutationsMark Kriegsmann, Alexander Harms, Daniel Kazdal, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 27, 2023
Response to "NGS, the New Global Standard?"Sai-Hong Ignatius Ou, Jin-Liern Hong, Petros Christopoulos, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 4, 2023
Distribution and Detectability of EGFR Exon 20 Insertion Variants in NSCLCSai-Hong Ignatius Ou, Jin-Liern Hong, Petros Christopoulos, et al.
Lung Cancer (Amsterdam, Netherlands)|March 7, 2020
Quantifying potential confounders of panel-based tumor mutational burden (TMB) measurementJan Budczies, Daniel Kazdal, Michael Allgäuer, et al.
Pageof 12

Showing results (31-40 of 116) with videos related to

Sort By:
Pageof 12
Proteomics|December 14, 2017
Proteomics in PathologyRémi Longuespée, Rita Casadonte, Kristina Schwamborn, et al.
Proteomics. Clinical Applications|August 13, 2017
MALDI Imaging-Guided Microproteomic Analyses of Heterogeneous Breast Tumors-A Pilot StudyDeborah Alberts, Charles Pottier, Nicolas Smargiasso, et al.
NPJ Precision Oncology|July 3, 2026
Mutation enrichment in targeted panels flags immunotherapy-responsive POLE-driven hypermutated microsatellite-stable colorectal cancersNic Gabriel Reitsam, Kathrin Anna Schneider, Bianca Grosser, et al.
Case Reports in Oncology|May 12, 2021
Combination of Crizotinib and Osimertinib in T790M+ EGFR-Mutant Non-Small Cell Lung Cancer with Emerging MET Amplification Post-Osimertinib Progression in a 10-Year Survivor: A Case ReportMiriam Blasi, Daniel Kazdal, Michael Thomas, et al.
Proteomics. Clinical Applications|September 15, 2018
In MALDI-Mass Spectrometry Imaging on Formalin-Fixed Paraffin-Embedded Tissue Specimen Section Thickness Significantly Influences m/z Peak IntensityRémi Longuespée, Katharina Kriegsmann, Martin Cremer, et al.
Cell Death Discovery|April 14, 2023
Homogenous TP53mut-associated tumor biology across mutation and cancer types revealed by transcriptome analysisEva Romanovsky, Klaus Kluck, Iordanis Ourailidis, et al.
Pathology, Research and Practice|March 1, 2018
Analysis of the proliferative activity in lung adenocarcinomas with specific driver mutationsMark Kriegsmann, Alexander Harms, Daniel Kazdal, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 27, 2023
Response to "NGS, the New Global Standard?"Sai-Hong Ignatius Ou, Jin-Liern Hong, Petros Christopoulos, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 4, 2023
Distribution and Detectability of EGFR Exon 20 Insertion Variants in NSCLCSai-Hong Ignatius Ou, Jin-Liern Hong, Petros Christopoulos, et al.
Lung Cancer (Amsterdam, Netherlands)|March 7, 2020
Quantifying potential confounders of panel-based tumor mutational burden (TMB) measurementJan Budczies, Daniel Kazdal, Michael Allgäuer, et al.
Pageof 12